MAP3K7 and metabolic syndrome: Our findings of upregulation of HSP 60 and TAK1-TAB1 in CAD patients compared to HC, along with their negative correlation with LDL cholesterol levels in HC patients, suggest potential roles for these proteins in atherosclerosis and dyslipidemia.